Little Cigar and Cigarillo Warnings Among US Adults Who Use LCCs
2 other identifiers
interventional
1,029
1 country
1
Brief Summary
The goal of this research is to assess whether little Cigars and cigarillos (LCC) warnings developed by the study team are more effective than the current warnings proposed by FDA for LCC products. A 3-week web-based randomized controlled trial will be conducted in the United States. Participants are adult persons who currently use LCCs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 26, 2023
CompletedFirst Posted
Study publicly available on registry
May 8, 2023
CompletedStudy Start
First participant enrolled
May 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 27, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 27, 2023
CompletedResults Posted
Study results publicly available
January 8, 2025
CompletedJanuary 8, 2025
January 1, 2025
3 months
April 26, 2023
December 10, 2024
January 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
LCC Quit Intentions
Average quit intention score measured by survey. Quit intention measured with 3 questions, the final quit intention score is a mean of the response to the 3 questions, on a scale of 1 to 4, where 1 indicates low intention to quit, and 4 indicates a high intention to quit.
day 21 (post test)
Secondary Outcomes (39)
Number of LCCs Smoked in Past Day
day 1
Number of LCCs Smoked in Past Day
day 2
Number of LCCs Smoked in Past Day
day 3
Number of LCCs Smoked in Past Day
day 4
Number of LCCs Smoked in Past Day
day 5
- +34 more secondary outcomes
Study Arms (3)
Newly developed warnings with images
EXPERIMENTALParticipants receive newly developed warnings intervention
FDA proposed text-only warnings
EXPERIMENTALParticipants receive FDA proposed text only warning intervention
Control group, no intervention
NO INTERVENTIONParticipants do not receive an intervention
Interventions
On study days 1-6, 8-13 and 15-20, participants in this condition will view an image of a little cigar and cigarillo package with a warning developed by the study team that includes an image. The warnings will take up 30% of the package. Participants will view a total of 6 different warnings over the course of 6 days each week, this will be repeated 3 times during the study, resulting in a total of 18 exposures. Participants will be required to view the warning for at least 5 seconds.
On study days 1-6, 8-13 and 15-20, participants in this condition will view an image of a little cigar and cigarillo package with a warning proposed by the FDA which is text only. The warnings will take up 30% of the package. Participants will view a total of 6 different warnings over the course of 6 days each week, this will be repeated 3 times during the study, resulting in a total of 18 exposures. Participants will be required to view the warning for at least 5 seconds.
Eligibility Criteria
You may qualify if:
- Members of the recruitment panel (the investigators are partnering with a panel provider for recruitment of all participants)
- Agree to provide their honest answers
- Current little cigar and/or cigarillo every day or some day users
- Over 21 years old
- Currently living in US
- Feel comfortable taking a survey in English without help
- Feel comfortable taking an online survey without help
- Have an email address that they check regularly
- Have access to the internet at work or home
- Able to read and respond to surveys delivered to their email
- Able to complete 2 surveys that take approximately 20 minutes
- Able to complete a 5 minute survey each day for 20 days
- Able to verify they are not a bot using CAPTCHA
- Able to answer a simple, random math question
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599, United States
Related Publications (1)
Goldstein AO, Jarman KL, Ranney LM, Cornacchione Ross J, Kowitt SD, Enyioha C, Clark SA, Sheeran P, Thrasher JF, Jenson D, Vielot NA. Little Cigar and Cigarillo Graphic Health Warnings and Quitting Behaviors: A Randomized Clinical Trial. JAMA Netw Open. 2025 Aug 1;8(8):e2526799. doi: 10.1001/jamanetworkopen.2025.26799.
PMID: 40815515DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Adam O Goldstein
- Organization
- UNC Lineberger Comprehensive Cancer Center
Study Officials
- PRINCIPAL INVESTIGATOR
Adam O Goldstein
the University of North Carolina (UNC) Department of Family Medicine
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 26, 2023
First Posted
May 8, 2023
Study Start
May 22, 2023
Primary Completion
August 27, 2023
Study Completion
August 27, 2023
Last Updated
January 8, 2025
Results First Posted
January 8, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- The supporting documents and data will become available when study results are submitted to ClinicalTrials.gov. Deidentified study data sets will be available, by request, following publication of the study's main findings.
- Access Criteria
- The investigators will decide whether to share deidentified study data sets on a case by case basis, and will prioritize sharing the data sets with qualified tobacco regulatory science researchers.
The investigators will make data collection instruments available for public use after data collection and analyses are complete. On request, the investigators will also make data sets available, stripped of individual identifiers, following publication of the study's main findings.